BioCentury
ARTICLE | Financial News

Arrakis raises $38M to pursue RNA platform

February 28, 2017 12:11 AM UTC

RNA specialist Arrakis Therapeutics Inc. (Waltham, Mass.) emerged from stealth mode on Monday and raised a tranched $38 million series A round led by new investor Canaan Partners.

New investors Pfizer Inc. (NYSE:PFE), Celgene Corp. (NASDAQ:CELG) and Osage University Partners also participated with existing investors Advent Life Sciences and Henri Termeer. The size of the tranche was not disclosed. ...